LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,666,325 | +5.3% | 61,187 | +26.8% | 0.01% | +14.3% |
| Q2 2023 | $3,480,195 | -8.3% | 48,269 | -8.1% | 0.01% | -12.5% |
| Q1 2023 | $3,796,697 | +84.9% | 52,524 | +68.8% | 0.01% | +60.0% |
| Q4 2022 | $2,053,750 | -16.7% | 31,108 | +8.6% | 0.01% | -16.7% |
| Q3 2022 | $2,466,000 | +61.4% | 28,639 | +62.6% | 0.01% | +100.0% |
| Q2 2022 | $1,528,000 | +77.5% | 17,613 | +130.2% | 0.00% | +50.0% |
| Q1 2022 | $861,000 | +151.8% | 7,651 | +245.3% | 0.00% | +100.0% |
| Q4 2021 | $342,000 | -30.5% | 2,216 | -37.2% | 0.00% | 0.0% |
| Q3 2021 | $492,000 | -71.0% | 3,530 | -72.7% | 0.00% | -66.7% |
| Q2 2021 | $1,697,000 | +103.5% | 12,934 | +136.4% | 0.00% | +200.0% |
| Q1 2021 | $834,000 | -70.5% | 5,472 | -80.8% | 0.00% | -80.0% |
| Q4 2020 | $2,829,000 | +15.3% | 28,449 | +10.6% | 0.01% | +25.0% |
| Q3 2020 | $2,453,000 | -49.9% | 25,732 | -41.3% | 0.00% | -50.0% |
| Q2 2020 | $4,900,000 | -61.3% | 43,809 | -74.9% | 0.01% | -61.9% |
| Q1 2020 | $12,668,000 | -41.3% | 174,203 | -15.8% | 0.02% | -16.0% |
| Q4 2019 | $21,571,000 | -17.1% | 206,835 | -20.9% | 0.02% | -19.4% |
| Q3 2019 | $26,015,000 | +80.8% | 261,352 | +107.3% | 0.03% | +93.8% |
| Q2 2019 | $14,390,000 | +48.9% | 126,066 | +63.9% | 0.02% | +60.0% |
| Q1 2019 | $9,667,000 | +13.0% | 76,900 | +21.9% | 0.01% | 0.0% |
| Q4 2018 | $8,558,000 | +19.8% | 63,065 | +142.4% | 0.01% | +42.9% |
| Q3 2018 | $7,142,000 | +68.1% | 26,020 | +26.9% | 0.01% | +75.0% |
| Q2 2018 | $4,248,000 | +43.7% | 20,503 | +14.5% | 0.00% | +33.3% |
| Q1 2018 | $2,957,000 | +42.4% | 17,904 | +18.1% | 0.00% | +50.0% |
| Q4 2017 | $2,076,000 | +94.2% | 15,162 | +93.1% | 0.00% | +100.0% |
| Q3 2017 | $1,069,000 | +35.8% | 7,850 | +1.3% | 0.00% | 0.0% |
| Q4 2016 | $787,000 | -70.4% | 7,750 | -70.3% | 0.00% | -75.0% |
| Q3 2016 | $2,660,000 | -23.1% | 26,060 | -10.2% | 0.00% | -33.3% |
| Q2 2016 | $3,460,000 | -10.3% | 29,013 | -19.4% | 0.01% | -14.3% |
| Q1 2016 | $3,856,000 | +81.4% | 36,004 | +83.7% | 0.01% | +75.0% |
| Q4 2015 | $2,126,000 | +97.4% | 19,604 | +55.9% | 0.00% | +100.0% |
| Q3 2015 | $1,077,000 | +41.7% | 12,576 | +67.0% | 0.00% | 0.0% |
| Q2 2015 | $760,000 | -21.4% | 7,529 | -63.4% | 0.00% | -33.3% |
| Q3 2014 | $967,000 | -33.3% | 20,577 | -11.6% | 0.00% | -25.0% |
| Q2 2014 | $1,450,000 | -7.8% | 23,277 | -0.4% | 0.00% | -20.0% |
| Q1 2014 | $1,572,000 | +43.2% | 23,377 | +12.0% | 0.01% | +66.7% |
| Q4 2013 | $1,098,000 | +95.4% | 20,877 | +60.9% | 0.00% | +50.0% |
| Q3 2013 | $562,000 | +15.6% | 12,979 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $486,000 | +80.7% | 12,979 | 0.0% | 0.00% | +100.0% |
| Q4 2012 | $269,000 | – | 12,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |